Jan. 5 (Bloomberg) -- Weight-loss treatments need more study to prove they also help people live longer before doctors can be sure the benefits are greater than the risks and that the high cost is justified, researchers said in today's Lancet.
While drugs such as Roche Holding AG's Xenical and Abbott Laboratories' Meridia have proven to help patients lose weight, tests that show treatments save lives or cut deadly risks such as heart disease should be required, Raj Padwal and Sumit Majumdar of the University of Alberta Hospital in Edmonton said in the journal.
Roche, Abbott and France's Sanofi-Aventis SA already sell weight-loss products and the rising level of obesity around the world is attracting Pfizer Inc. and Merck & Co. Sedentary lifestyles and high-fat diets have caused the number of obese Americans to double over the past 30 years to around 31 percent of the population, according to the U.S. government. About 65 percent of the population is classed as overweight.
A lung cancer drug that has been taken off the shelf in the US market is much more likely to prove effective in some Taiwanese lung cancer patients, according to a local study that was recently published in the journal Lung Cancer.
(CP) -
Another article
SAUDI - The herbal medicine industry is not immune to the manipulation of imposters in the field. People seeking treatment for their ailments are sometimes deceived by practitioners who prescribe harmful herbal medicines and concoctions. An extremely competitive lucrative business has appeared on the markets in Saudi Arabia of late, evidence of which may be seen in the newspapers and pamphlets that advertise remedies claiming to be able to succeed where the jinns and Aladdin’s lamp have failed. Those afflicted are easily manipulated by confident claims to cure diseases that the doctors could not, forking out large sums of money in the vain hope of being relieved of their symptoms. Imposters in the field use plants of an inferior quality and mix them with chemicals to provide immediate positive results. The effects soon wear off however, and it can sometimes be difficult to save the lives of people whose health is severely affected by these bad treatments.
The drug sildenafil, popularly known as Viagra, may help people with chronic obstructive pulmonary disease control the illness-related blood pressure spikes in the heart's pulmonary artery, a new study found.